591 related articles for article (PubMed ID: 10420461)
21. The renin-angiotensin-aldosterone system in terminal renal failure.
Weidmann P; Maxwell MH
Kidney Int Suppl; 1975 Sep; ():S219-34. PubMed ID: 1104972
[No Abstract] [Full Text] [Related]
22. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients.
Mimran A; Shaldon S; Barjon P; Mion C
Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368
[TBL] [Abstract][Full Text] [Related]
23. [The treatment of severe arterial hypertension in patients with chronic kidney failure with captopril and beta-adrenoblockaders].
Ermolenko VM; Lifshits NL; Zisel'man SB; Tatsievskiĭ VA
Urol Nefrol (Mosk); 1991; (3):41-8. PubMed ID: 1871923
[TBL] [Abstract][Full Text] [Related]
24. [The activities of the renin-angiotensin-aldosterone and sympathetic-adrenal systems during hemodialysis].
Akopian AS; Koriakin MV; Golubov AA; Shevchenko AV
Urol Nefrol (Mosk); 1991; (4):45-50. PubMed ID: 1659015
[TBL] [Abstract][Full Text] [Related]
25. Negative association between plasma aldosterone concentration/plasma renin activity and morning blood pressure surge in never-treated hypertensive patients.
Cho JS; Ihm SH; Jang SW; Chung WB; Choi YS; Shin DI; Seo SM; Park MW; Kim GH; Her SH; Kim CJ; Kim TH; Kang MK; Chang K; Park CS
Clin Exp Hypertens; 2014; 36(4):195-9. PubMed ID: 24678899
[TBL] [Abstract][Full Text] [Related]
26. Increased levels of plasma renin, aldosterone, catecholamines and vasopressin in chronic ambulatory peritoneal dialysis (CAPD) patients.
Zabetakis PM; Kumar DN; Gleim GW; Gardenswartz MH; Agrawal M; Robinson AG; Michelis MF
Clin Nephrol; 1987 Sep; 28(3):147-51. PubMed ID: 3311503
[TBL] [Abstract][Full Text] [Related]
27. [Activity of the renin-angiotensin-aldosterone system and its impact on the effectiveness of treatment of chronic heart failure in patients with pulmonary tuberculosis].
Radzevich AE; Ditiatkov AE; Tikhonov VA
Probl Tuberk; 2001; (5):16-9. PubMed ID: 11588951
[TBL] [Abstract][Full Text] [Related]
28. [Clinical pharmacology of enalapril in hypertension with chronic renal failure].
Chaignon M; Billaud-Mesguich E; Alexandre JM; Guédon J
Arch Mal Coeur Vaiss; 1986 Jun; 79(6):967-70. PubMed ID: 3026274
[TBL] [Abstract][Full Text] [Related]
29. Low plasma renin activity and high aldosterone/renin ratio are associated with untreated isolated systolic hypertension.
Durukan M; Guray U; Aksu T; Guray Y; Demirkan B; Korkmaz S
Blood Press; 2012 Oct; 21(5):320-5. PubMed ID: 22587638
[TBL] [Abstract][Full Text] [Related]
30. [The renin-angiotensin-aldosterone system and arterial hypertension in patients with rheumatoid arthritis].
Samoriadova OS; Zharova EA; Masenko VP; Balabanova RM; Vil'chinskaia MIu; Nasonov EL
Klin Med (Mosk); 1991 Feb; 69(2):69-71. PubMed ID: 1875668
[TBL] [Abstract][Full Text] [Related]
31. Influence of dietary sodium on the renin-angiotensin-aldosterone system and prevalence of left ventricular hypertrophy by EKG criteria.
Williams JS; Williams GH; Jeunemaitre X; Hopkins PN; Conlin PR
J Hum Hypertens; 2005 Feb; 19(2):133-8. PubMed ID: 15361890
[TBL] [Abstract][Full Text] [Related]
32. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A
Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298
[TBL] [Abstract][Full Text] [Related]
33. Dopamine control of aldosterone secretion in end-stage renal failure.
García-Robles R; Ruilope L; Tovar J; de Villa LF; Miranda B; Prieto C; Parada J; Sancho J; Rodicio JL
Rev Esp Fisiol; 1986 Jun; 42(2):257-63. PubMed ID: 3092288
[TBL] [Abstract][Full Text] [Related]
34. Plasma atrial natriuretic peptide and its relation to the renin-angiotensin-aldosterone system in patients with chronic renal failure.
Selçuk Y; San A; Bakan E; Yiğitoğlu R
Nephrol Dial Transplant; 1991; 6(8):557-61. PubMed ID: 1835523
[TBL] [Abstract][Full Text] [Related]
35. Plasma aldosterone during haemodialysis in patients with terminal renal failure.
Vetter W; Záruba K; Armbuster H; Strebel U; Beckerhoff R; Siegenthaler W
Proc Eur Dial Transplant Assoc; 1973; 10(0):332-41. PubMed ID: 4370265
[No Abstract] [Full Text] [Related]
36. Catecholamines, sodium and renin in unilateral renal hypertension in man.
Weidmann P; Schiffl H; Ziegler WH; Glück Z; Meier A; Keusch G
Miner Electrolyte Metab; 1982 Feb; 7(2):97-112. PubMed ID: 6763143
[TBL] [Abstract][Full Text] [Related]
37. [Behavior of the renin-angiotensin-aldosterone system and vasopressin secretion in patients with renovascular hypertension or small kidney].
Wieçek A; Kokot F
Z Gesamte Inn Med; 1985 Mar; 40(6):172-6. PubMed ID: 3890386
[TBL] [Abstract][Full Text] [Related]
38. [Age-related changes in the renin-angiotensin-aldosterone system and the sympathetic nervous system in patients with essential hypertension].
Nami R; Martinelli M; Panza F; Pavese G; Carletti F; Buracchi P; Lucani B; Pazzaglia A; Saia F; Gennari C
Minerva Cardioangiol; 1993 Sep; 41(9):387-95. PubMed ID: 8259235
[TBL] [Abstract][Full Text] [Related]
39. [RAAS changes due to dysfunction of pulmonary ventilation].
Lin Y; Sun M; Ma Y
Zhonghua Jie He He Hu Xi Za Zhi; 1996 Apr; 19(2):84-7. PubMed ID: 9388845
[TBL] [Abstract][Full Text] [Related]
40. Control of plasma aldosterone during chronic hemodialysis.
Studer A; Záruba K; Grimm J; Kuhlmann U; Siegenthaler W; Vetter W
Clin Nephrol; 1980 Apr; 13(4):172-6. PubMed ID: 6991183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
